Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.
Fajgenbaum DC, Wu D, Goodman A, Wong R, Chadburn A, Nasta S, Srkalovic G, Mukherjee S, Leitch H, Jayanthan R, Ferrero S, Sato Y, Schey S, Dispenzieri A, Oksenhendler E, Zinzani PL, Lechowicz MJ, Hoffmann C, Pemmaraju N, Bagg A, Fossa A, Lim MS, van Rhee F; Castleman Disease Collaborative Network Scientific Advisory Board diagnostic criteria international working group and treatment guidelines international working group.
Fajgenbaum DC, et al.
Am J Hematol. 2020 Dec;95(12):1553-1561. doi: 10.1002/ajh.25992. Epub 2020 Sep 25.
Am J Hematol. 2020.
PMID: 32894785
Free PMC article.
Clinical Trial.